Hyperfine Inc (HYPR) FinancialsHYPRHyperfine Inc

Hyperfine, Inc. (HYPR) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is DEVICE, accounting for 83.4% of total sales, equivalent to $3.26M. Another important revenue stream is SERVICE. Understanding this composition is critical for investors evaluating how HYPR navigates market cycles within the Advanced Medical Equipment & Technology industry.

Evaluating the bottom line, Hyperfine, Inc. maintains a gross margin of 50.72%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -216.93%, while the net margin is -238.17%. These profitability ratios, combined with a Return on Equity (ROE) of -96.97%, provide a clear picture of how effectively HYPR converts its operational activities into shareholder value.

In the context of the broader market, HYPR competes directly with industry leaders such as OM and WRAP. With a market capitalization of $79.57M, it holds a significant position in the sector. When comparing efficiency, HYPR's gross margin of 50.72% stands against OM's 40.69% and WRAP's 75.29%. Such benchmarking helps identify whether Hyperfine, Inc. is trading at a premium or discount relative to its financial performance.

Hyperfine has shown a gross margin of 50.72% in Q2 2026, indicating strong profitability on sales. However, the company has consistently reported negative net income, with losses reaching -$9,298,000 in Q2 2026, which raises concerns about its financial health.